Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psychiatric problems in internal practice. Part I].

E Cesková1

  • 1Psychiatrická klinika LF MU a FN, Brno-Bohunice. eceska@med.muni.cz

Casopis Lekaru Ceskych
|November 13, 2001
PubMed
Summary

Depression is common in cardiovascular disease patients, increasing morbidity and mortality. New antidepressants with fewer cardiovascular effects offer promising treatment options for these complex cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aldosterone and aldosterone/cortisol ratio is higher in serum of long-term compared to first episode schizophrenia patients: A pilot study.

Journal of psychiatric research·2018
Same author

Treatment of panic disorder: Algorithms for pharmacotherapy.

International journal of psychiatry in clinical practice·2014
Same author

Optimizing treatment with risperidone long-acting injections.

Acta psychiatrica Scandinavica·2012
Same author

[Compliance in psychiatry].

Casopis lekaru ceskych·2010
Same author

[Hippocampus, structure of the brain and schizophrenia].

Casopis lekaru ceskych·2006
Same author

[Mutational analysis of LQT genes in individuals with drug induced QT interval prolongation].

Vnitrni lekarstvi·2006

Area of Science:

  • Cardiology
  • Psychiatry
  • Internal Medicine

Context:

  • Depression frequently co-occurs with cardiovascular disease (CVD).
  • Cardiovascular complications significantly contribute to morbidity and mortality in depressed patients.
  • Shared etiopathogenic factors link depression and CVD, including endocrine, immune, personality, and lifestyle elements.

Purpose:

  • To review the complex relationship between depression and cardiovascular disease.
  • To highlight diagnostic challenges of depression in medically ill patients.
  • To explore potential treatment strategies and the role of novel pharmacotherapies.

Summary:

  • Depression is a significant comorbidity in cardiovascular disease, exacerbating patient outcomes.
  • Identifying depression in patients with somatic diseases can be challenging but is crucial.
  • Emerging antidepressant medications with reduced cardiovascular impact show promise for internal medicine settings.

Impact:

  • Underscores the need for integrated care approaches in managing comorbid depression and CVD.
  • Highlights the potential of new pharmacological treatments to improve patient prognosis.
  • Emphasizes the importance of interdisciplinary collaboration between cardiologists, psychiatrists, and internists.

Related Experiment Videos